stockrowUFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) Total debt
UFP Technologies, Inc.'s total debt at the end of fiscal 2025 was $149.4M, down 25.9% from $201.8M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $96.0M. Over the past ten years it has ranged from $856.0K (fiscal 2016) to $201.8M (fiscal 2024); the current reading is higher than 90% of that period. UFP Technologies, Inc. ranks 42nd of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $149.4M | (25.95%) |
| FY2024 | $201.8M | 530.65% |
| FY2023 | $32.0M | (41.82%) |
| FY2022 | $55.0M | (33.02%) |
| FY2021 | $82.1M | 6,443.27% |
| FY2020 | $1.3M | (59.39%) |
| FY2019 | $3.1M | (87.71%) |
| FY2018 | $25.1M | 2,837.27% |
| FY2016 | $856.0K | (54.22%) |
| FY2015 | $1.9M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $96.0M | (27.05%) |
| Jun 2026 | $131.6M | (12.88%) |
| Mar 2026 | $151.1M | 1.07% |
| Dec 2025 | $149.4M | (6.92%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| NEOG Neogen Corporation compare | $774.2M |
| ESTA Establishment Labs Holdings Inc. compare | $261.7M |
| NVCR NovoCure Limited compare | $196.3M |
| UFPT UFP Technologies, Inc. | $96.0M |
| TMDX TransMedics Group, Inc. compare | $54.8M |
| INSP Inspire Medical Systems, Inc. compare | $25.2M |
| BFLY Butterfly Network, Inc. compare | $23.4M |
| AXGN AxoGen, Inc. compare | $17.6M |
| ALMR Alamar Biosciences, Inc. compare | $9.9M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement